Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sabrina Solis

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Biorxiv : the Preprint Server for Biology|November 23, 2022
Inflammation durably imprints memory CD4+ T cellsSophie L Gray-Gaillard, Sabrina Solis, Han M Chen, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Lymphatic constraint of germinal centers optimizes protective antibody responsesTenny Mudianto, Gabrielle R Berman, Kimberly Zaldana, et al.
Nature Immunology|December 20, 2024
Efficacy of CTLA-4 checkpoint therapy is dependent on IL-21 signaling to mediate cytotoxic reprogramming of PD-1<sup>+</sup>CD8<sup>+</sup> T cellsZhen Zhang, Marlene Langenbach, Sagar Sagar, et al.
Cell Reports|October 27, 2023
KEAP1 mutation in lung adenocarcinoma promotes immune evasion and immunotherapy resistanceAnastasia-Maria Zavitsanou, Ray Pillai, Yuan Hao, et al.
Cancer Cell|August 30, 2024
Combination anti-PD-1 and anti-CTLA-4 therapy generates waves of clonal responses that include progenitor-exhausted CD8<sup>+</sup> T cellsKevin Wang, Paulina Coutifaris, David Brocks, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Biorxiv : the Preprint Server for Biology|November 23, 2022
Inflammation durably imprints memory CD4+ T cellsSophie L Gray-Gaillard, Sabrina Solis, Han M Chen, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Lymphatic constraint of germinal centers optimizes protective antibody responsesTenny Mudianto, Gabrielle R Berman, Kimberly Zaldana, et al.
Nature Immunology|December 20, 2024
Efficacy of CTLA-4 checkpoint therapy is dependent on IL-21 signaling to mediate cytotoxic reprogramming of PD-1<sup>+</sup>CD8<sup>+</sup> T cellsZhen Zhang, Marlene Langenbach, Sagar Sagar, et al.
Cell Reports|October 27, 2023
KEAP1 mutation in lung adenocarcinoma promotes immune evasion and immunotherapy resistanceAnastasia-Maria Zavitsanou, Ray Pillai, Yuan Hao, et al.
Cancer Cell|August 30, 2024
Combination anti-PD-1 and anti-CTLA-4 therapy generates waves of clonal responses that include progenitor-exhausted CD8<sup>+</sup> T cellsKevin Wang, Paulina Coutifaris, David Brocks, et al.
Pageof 1